BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$2.11B |
| 2 |
Veralto
VLTO
|
+$1.29B |
| 3 |
Blackstone
BX
|
+$1.1B |
| 4 |
Extra Space Storage
EXR
|
+$964M |
| 5 |
Airbnb
ABNB
|
+$935M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$2.47B |
| 2 |
Apple
AAPL
|
+$1.51B |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$1.29B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$1.09B |
| 5 |
NVIDIA
NVDA
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Healthcare | 13.55% |
| 3 | Financials | 11.73% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTHX
3876
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.61M | ﹤0.01% |
1,120,307
-65,338
| -6% | -$126K |
|
3877
dLocal
DLO
$4.44B
| $1.61M | ﹤0.01% |
84,148
-35,512
| -30% | -$604K |
|
|
GRCL
3878
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $1.61M | ﹤0.01% |
559,445
+42,036
| +8% | +$154K |
|
3879
B2Gold
BTG
$5B
| $1.6M | ﹤0.01% |
554,940
+173,425
| +45% | +$564K |
|
3880
Apyx Medical
APYX
$173M
| $1.59M | ﹤0.01% |
498,415
-36,339
| -7% | -$169K |
|
3881
Nuveen Municipal Value Fund
NUV
$1.92B
| $1.58M | ﹤0.01% |
191,065
-191,068
| -50% | -$1.63M |
|
3882
INmune Bio
INMB
$46.5M
| $1.58M | ﹤0.01% |
232,824
-6,809
| -3% | -$56.5K |
|
|
EGIO
3883
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.57M | ﹤0.01% |
46,184
-137
| -0.3% | -$4.29K |
|
3884
OPAL Fuels
OPAL
$71.3M
| $1.57M | ﹤0.01% |
191,611
+190,926
| +27,872% | +$1.4M |
|
3885
OppFi
OPFI
$800M
| $1.55M | ﹤0.01% |
616,738
-132,160
| -18% | -$308K |
|
3886
American Resources Corp
AREC
$191M
| $1.54M | ﹤0.01% |
921,957
-8,103
| -0.9% | -$12.9K |
|
|
FONR
3887
DELISTED
Fonar
FONR
| $1.54M | ﹤0.01% |
99,819
-990
| -1% | -$16.4K |
|
3888
iShares US Consumer Discretionary ETF
IYC
$1.17B
| $1.53M | ﹤0.01% |
+22,784
| New | +$1.61M |
|
3889
Kenon Holdings
KEN
$3.51B
| $1.52M | ﹤0.01% |
67,159
-14,391
| -18% | -$350K |
|
|
MDV
3890
Modiv Industrial
MDV
$179M
| $1.52M | ﹤0.01% |
98,740
-888
| -0.9% | -$11.2K |
|
|
SUP
3891
DELISTED
Superior Industries International
SUP
| $1.51M | ﹤0.01% |
497,441
-71,605
| -13% | -$252K |
|
3892
BGSF Inc
BGSF
$59.5M
| $1.51M | ﹤0.01% |
157,134
-20,388
| -11% | -$201K |
|
|
HYZN
3893
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $1.5M | ﹤0.01% |
23,960
-1,906
| -7% | -$129K |
|
3894
Transact Technologies
TACT
$53.2M
| $1.48M | ﹤0.01% |
230,924
-10,131
| -4% | -$76.6K |
|
3895
Ocugen
OCGN
$416M
| $1.48M | ﹤0.01% |
3,693,281
-214,133
| -5% | -$106K |
|
|
DDL
3896
Dingdong
DDL
$562M
| $1.47M | ﹤0.01% |
755,735
-48,986
| -6% | -$113K |
|
3897
CytomX Therapeutics
CTMX
$675M
| $1.47M | ﹤0.01% |
1,139,636
-8,180
| -0.7% | -$12.9K |
|
3898
Caesarstone
CSTE
$72.3M
| $1.47M | ﹤0.01% |
343,479
+46,962
| +16% | +$226K |
|
|
CHMI
3899
Cherry Hill Mortgage Investment Corp
CHMI
$83M
| $1.47M | ﹤0.01% |
394,680
-22,089
| -5% | -$90.5K |
|
|
FIRY
3900
Firy Inc
FIRY
$148M
| $1.47M | ﹤0.01% |
287,867
-14,368
| -5% | -$128K |
|
Similar funds
BlackRock's Q3 2023 Portfolio in Review
As of Q3 2023, BlackRock held 5,656 positions worth $3.48T, down 4.1% from $3.63T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BlackRock's Q3 2023 filing shows 156 new, 2,077 increased, 2,595 reduced and 210 closed positions. Its largest new stake was Veralto: 15,466,356 shares worth $1.31B. The largest sale was Johnson & Johnson, an estimated $2.47B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2023 buy was Veralto: 15,466,356 shares worth $1.31B.
- BlackRock added most to Kenvue in Q3 2023, an estimated $2.11B increase.
- BlackRock's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $2.47B.
- BlackRock fully exited Life Storage, Inc. in Q3 2023, selling an estimated $1.29B.
- BlackRock's ten largest holdings make up 22% of its $3.48T portfolio in Q3 2023.
- BlackRock opened 156 new positions and closed 210 in Q3 2023.
- BlackRock's portfolio value fell 4.1% quarter-over-quarter to $3.48T.
Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.